MedTrace Logo

Dermacyd Infantile - Acceptability.

NCT00881270 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2009-09-28

No results posted yet for this study

Summary

Primary Objective:

To prove the safety of the formulation in normal conditions of use.

Conditions

  • Hygiene

Interventions

DRUG

LACTIC ACID(ND)

Dermacyd Infantile (LACTIC ACID)

Sponsors & Collaborators

Principal Investigators

  • Jaderson Lima · Sanofi

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2009-03-31
Completion
2009-03-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00881270 on ClinicalTrials.gov